WASHINGTON, D.C. (January 25, 2011) – Debra Lappin, president of The Council for American Medical Innovation (CAMI), a partnership of leaders in research, medicine, patient advocacy, academia, education, labor and business dedicated to advancing medical innovation, issued the following statement today on the call by the Director of the National Institutes of Health (NIH) to create a new National Center for Advancing Translational Sciences.
“The Council commends Director Collins for this leadership, and we are pleased to see the call for this new center, focused on moving basic research into early phase drug development, gain national and international attention. Through our conversations with stakeholders across the country, and as outlined in our 2010 report, Gone Tomorrow? A Call to Promote Medical Innovation, Create Jobs, and Find Cures in America, public-private partnerships are key to fostering the innovative climate we need to find cures, reduce health care costs, and ensure our nation’s continued global leadership and competitiveness.
“The current regulatory and capital environment makes it increasingly difficult to embark on a billion dollar, 15-year drug development process, and yet private industry has continued to invest billions into research that leads to potential life changing medicines for Americans. Federal leadership, as we are seeing from NIH, will help move potential new discoveries out of the lab and into early phase trials, and in this process bridge the widening gap between our world renowned federal research enterprise and therapeutic applications that improve human health.
“We look forward to working with Dr. Collins and the NIH as the effort to create the Center for Advancing Translational Sciences moves forward and to supporting other bold actions that ensure a continued, robust medical innovation infrastructure across the United States.”